L
Larimar Therapeutics, Inc. (LRMR)
NGM – Real Time Price. Currency in USD
3.66
+0.16 (4.57%)
At close: Jun 26, 2026, 4:00 PM EDT
4.00
+0.34 (9.29%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
3.66
+0.16 (4.57%)
At close: Jun 26, 2026, 4:00 PM EDT
4.00
+0.34 (9.29%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $177.9M significantly exceed its total debt $3.8M, ensuring strong financial flexibility
Total current assets $205.0M exceed Total current liabilities $47.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$44.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.29 | 6.05 | 10 | |
| Quick ratio | 4.29 | 5.63 | 10 | |
| Debt to Equity | 0.02 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -272K | -311K | -318K | -350K | -326K |
| Operating Income | -37M | -42M | -91M | -172M | -172M |
| Net Income | -35M | -37M | -81M | -166M | -166M |
| EBITDA | -36M | -41M | -91M | -172M | -172M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 3.43 | 2.5 |
| Next quarter | N/A | 28.98 | 5.5 |
| Current year | N/A | 26.77 | 5.5 |
| Next year | N/A | 24.28 | 5.5 |
| Weighted average score | 4.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 52.62 | 57.53 | -15.79 | 7.8 |
| Y/Y | 999 | -1.12 | 32.61 | -67.78 | 5.5 |
| 3y average | 999 | -76.05 | -30.12 | -64.13 | 3.3 |
| 5y average | 999 | -43.42 | -3.88 | -31.59 | 3.3 |
| Weighted average score | 5.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |